HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakatoku, H. Articles by Inoue, S. Search for Related Content PubMed PubMed Citation Articles by Sakatoku, H. Articles by Inoue, S.

In Vitro Proliferation and Differentiation of Erythroid Progenitors of Cord Blood

^a Yamada Red Cross Hospital, Mie-ken, Japan;
^b Hurley Medical Center and Michigan State University College of Human Medicine, Flint, Michigan, USA

Key Words. Cord blood cells • Erythropoietin • Stem cell factor • Differentiation

Dr. Hiroyuki Sakatoku, Department of Pediatrics, Yamada Red Cross Hospital, 810 Takabuku Misono Watarai, Mie-ken, 516, Japan.

Stem cell factor (SCF) is known to synergize with erythropoietin (EPO) for erythropoiesis in vitro. Clonogenic assay and suspension culture were used to assess the effect of EPO alone or its combination with SCF on the proliferation and differentiation of erythroid progenitors of cord blood. Colony formation, increase in cell count, and cell cycling status for the proliferation as well as expression of Glycophorin A (Gly A) and hemoglobinization as the marker of differentiation were determined with each stimulation. The cell cycle status of the cells in suspension cultures was determined using FACScan after labeling of cells with propidium iodide. Expression of Gly A and degree of hemoglobinization were determined by FACScan and spectrophotometer on the cells plucked from colonies in semisolid culture. Larger increases in cell counts in suspension culture were observed with EPO + SCF after 12 days of inoculation than with EPO alone. Mean doubling time was 14.2 h with EPO + SCF and 22.7 h with EPO alone. The proportion of cells in S and G₂ + M phase in day 14 suspension culture was 48% with EPO + SCF and 43% with EPO alone (no significant difference). Mean colony counts per 10⁵ nonadherent mononuclear cells were 76 ± 14 with EPO + SCF and 51 ± 15 with EPO at day 14 (p < 0.05). The number of macroscopic colonies with > 0.5 mm diameter was 10.7 ± 1.2 with EPO + SCF and 0.3 ± 0.5 with EPO (p < 0.05). Percent of Gly A⁺ cells was 75% for both EPO + SCF and EPO colonies at day 14. Hemoglobin concentration/10⁵ cells at day 14 was 0.70 ± 0.17 µg with EPO + SCF, and 1.16 ± 0.32 µg with EPO alone (p < 0.05). In conclusion, SCF in the combination with EPO showed a synergistic effect for erythroid proliferation in colony number as well as colony size derived from cord blood, while SCF with EPO decreased hemoglobin synthesis but not Gly A expression at day 14.

This article has been cited by other articles:

				M. J.G. Southcott, M. J.A. Tanner, and D. J. Anstee The Expression of Human Blood Group Antigens During Erythropoiesis in a Cell Culture System Blood, June 15, 1999; 93(12): 4425 - 4435. [Abstract] [Full Text] [PDF]